SCHEMBL3965425

SCHEMBL3965425

CNC(=O)c1ccc2cc(-c3nc(NCCC4CCNCC4)ncc3C)sc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.40
ITGB3 P05106 4/20 0.36
ITGA2B P08514 4/20 0.36
PCSK9 Q8NBP7 1/20 0.35
CCNT1 O60563 1/20 0.35
CCNK O75909 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
CDK9 P50750 1/20 0.35
CDK12 Q9NYV4 1/20 0.35
USP30 Q70CQ3 1/20 0.34
PTK2 Q05397 1/20 0.34
MAPK14 Q16539 4/20 0.34
LCK P06239 2/20 0.34
ROCK2 O75116 1/20 0.34
KIT P10721 2/20 0.33
ADORA2B P29275 1/20 0.33
EP300 Q09472 1/20 0.33
SRC P12931 1/20 0.33
FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3965506 0.99 BRD4 (0.39) BRD4ITGB3ITGA2BPCSK9CCNT1
Hydrochloric Acid SCHEMBL3966573 0.94 BRD4 (0.38) BRD4ITGB3ITGA2BPCSK9CCNT1
SCHEMBL4073297 0.89 USP30 (0.39) BRD4PCSK9CCNT1CDK2CDK9
SCHEMBL3961531 0.89 BRD4 (0.38) BRD4ITGB3ITGA2BPCSK9MAPK14
SCHEMBL3968770 0.86 ACP1 (0.37) BRD4PCSK9CCNT1CCNKCCNE1
SCHEMBL3964511 0.85 LRRK2 (0.46) FLT3TYRO3
SCHEMBL3966820 0.84 DYRK2 (0.41) ADORA2BMERTK
Hydrochloric Acid SCHEMBL3962057 0.84 HRH4 (0.41) BRD4PCSK9CCNT1CDK2CDK9
Hydrochloric Acid SCHEMBL3964563 0.84 ACP1 (0.37) BRD4ITGB3ITGA2BPCSK9MAPK14
Hydrochloric Acid SCHEMBL3967074 0.83 DYRK2 (0.37) MAPK14LCKKITTYRO3MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed
US-7547691-B2 [4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases ELI LILLY AND COMPANY (US) 2009-06-16 US disclosed
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases ELI LILLY AND COMPANY 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases NFKBIA, IKBKB, IKBKG BRD4 28/4885ITGB3 4047/4885ITGA2B 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.